PDT Partners LLC Acquires New Position in Danaher Corporation $DHR

PDT Partners LLC acquired a new position in shares of Danaher Corporation (NYSE:DHR) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 3,900 shares of the conglomerate’s stock, valued at approximately $2,808,000.

Other institutional investors also recently bought and sold shares of the company. Palisade Capital Management LP purchased a new stake in shares of Danaher during the 2nd quarter valued at approximately $15,824,000. Canada Pension Plan Investment Board purchased a new position in Danaher in the second quarter worth approximately $32,918,000. Castlekeep Investment Advisors LLC acquired a new stake in Danaher during the second quarter worth $350,000. Castleark Management LLC acquired a new stake in Danaher during the second quarter worth $994,000. Finally, Element Capital Management LLC purchased a new stake in Danaher in the second quarter valued at $4,895,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Stock Down 0.0%

NYSE:DHR opened at $215.90 on Thursday. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The stock’s fifty day moving average is $197.93 and its two-hundred day moving average is $192.36. The stock has a market capitalization of $151.77 billion, a price-to-earnings ratio of 38.35, a price-to-earnings-growth ratio of 2.69 and a beta of 0.78. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. The business had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The company’s revenue was up 5.5% on a year-over-year basis. During the same period in the previous year, the firm posted $0.77 earnings per share. Research analysts anticipate that Danaher Corporation will post 8.53 EPS for the current year.

Analyst Ratings Changes

DHR has been the topic of several recent analyst reports. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $240.00 price target on shares of Danaher in a research note on Wednesday, July 22nd. Guggenheim reduced their price objective on shares of Danaher from $235.00 to $200.00 and set a “buy” rating on the stock in a report on Wednesday, July 22nd. Piper Sandler started coverage on shares of Danaher in a research report on Thursday, June 11th. They issued a “neutral” rating and a $200.00 target price on the stock. Stifel Nicolaus lowered their target price on shares of Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a research note on Wednesday, July 22nd. Finally, Wells Fargo & Company lowered their target price on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a research note on Wednesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $228.91.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.